Good morning. Diving into this week's AI news is as thrilling as Nicolas Cage's quest for treasure—except the only map we're following leads to the latest AI innovation. Happy 60th, Nic!
🗣️ ChatGPT Eyes Android Throne: Poised to become the default AI on Android, ChatGPT could redefine digital assistance, promising enhanced interactivity and competitive AI performance.
🔬 Nabla's AI Assistant for Doctors: Nabla secures $24M for AI clinical notes tool, enhancing healthcare with AI-driven documentation efficiency.
🤖 Microsoft and OpenAI's Legal Challenge: Authors sue over AI training practices, highlighting intellectual property rights in AI development debates.
🧬 Isomorphic Labs' AI-Driven Drug Discovery: Isomorphic partners with pharma giants for AI in drug research, leveraging AI to revolutionize the pharmaceutical industry.
🗣️ ChatGPT Set to Challenge Google Assistant's Android Reign: A Look at the AI Performance Battleground
OpenAI's ChatGPT is poised to potentially become the new default digital assistant for Android users, marking a groundbreaking shift in the landscape of mobile technology and artificial intelligence. This change could redefine our interaction with devices, as ChatGPT brings its conversational AI strengths to a field traditionally dominated by Google Assistant. Here's an analytical look at what this means against the backdrop of current digital assistant performance metrics.
Competing on Performance:
The entry of ChatGPT into the Android ecosystem introduces a formidable contender to the digital assistant space. The image below reveals the current performance rates of digital assistants like Google Assistant, Siri, and Alexa across tasks. Google Assistant leads in most categories, but the nuanced capabilities of ChatGPT, particularly in generating informative responses and understanding complex queries, could challenge this supremacy.
Implications for AI Assistants:
Should ChatGPT be integrated as a default Android assistant, we might witness a shift in these performance metrics. ChatGPT's advanced language models could enhance the accuracy and relevance of responses, potentially elevating the standards for what users expect from their digital assistants. Additionally, the “flow” of a conversation may greatly be improved. Having to say “Alexa” before every command or question works, but it doesn’t match the feeling of a real conversation. This integration would pressure competitors to innovate and set a new benchmark for AI interaction on mobile devices.
Data Privacy and User Trust:
As ChatGPT potentially enters the fray, addressing user concerns about privacy and data handling will be crucial, particularly given the extensive datasets used to train AI models. We will have to closely watch how ChatGPT balances sophisticated service delivery with respectful data management practices, which could become a key differentiator in user adoption.
The story is too familiar for sales teams:
Reviewing customer calls, writing follow-ups, battling with CRMs… a whopping 41% of your day is swallowed by non-selling tasks!
Attention automates it all for you. This AI wizard can:
Automatically log crucial call info into your CRM.
Write your follow-up emails from your calls while adopting your writing style.
Guide your sales reps within and post-call coaching.
Plus, they feed insights that generate an extra $250k in ARR per rep.
🔍 Nabla Secures $24M for AI-Driven Clinical Note Assistant
Nabla, a Paris-based startup, has raised $24 million in Series B funding, led by Cathay Innovation and ZEBOX Ventures, achieving a valuation of $180 million. This follows a major partnership with Kaiser Permanente's Permanente Medical Group. Nabla's AI assistant for doctors, designed to write clinical notes automatically, uses speech-to-text technology and a large language model to generate medical reports. Founded by ex-Wit.ai CEO Alexandre Lebrun, Nabla enhances administrative efficiency, allowing doctors to focus more on patients. Nabla, mainly serving U.S. clients, emphasizes privacy, only storing data with consent, and is exploring advanced AI models for future improvements. Watch the video below to learn more 👇️
🤖 Microsoft and OpenAI Face New Legal Battle Over AI Model Training Practices
Microsoft and OpenAI are facing another lawsuit in Manhattan federal court by authors Nicholas Basbanes and Nicholas Gage, who allege that their copyrighted works were improperly used to train OpenAI's GPT models, including ChatGPT. This class action suit adds to existing legal challenges from various authors, including George R.R. Martin and entities like The New York Times, against tech firms for similar claims. The plaintiffs argue that the use of their works in AI training is unauthorized and uncompensated, pointing to a growing debate over intellectual property rights in the era of AI-driven content creation.
🧬 Isomorphic Labs Partners with Pharma Leaders on $3B AI Drug Discovery Venture
Isomorphic Labs, a spin-out of Google's AI R&D division DeepMind, based in London, has formed strategic partnerships with pharmaceutical giants Eli Lilly and Novartis, valued at approximately $3 billion, to leverage AI in drug discovery. The deals include upfront payments of $45 million from Eli Lilly and $37.5 million from Novartis, plus potential billions in performance milestones. Isomorphic will utilize DeepMind's AlphaFold 2 AI technology, known for predicting protein structures, to identify new drug targets. Despite its limitations, as highlighted in a 'Nature' article, AlphaFold's scale and accuracy offer significant advancements in drug design. Isomorphic's focus is on innovative AI-driven approaches to developing life-changing medicines.
The Deep View is currently one of the world’s fastest-growing newsletters, adding thousands of AI enthusiasts a week to our incredible family of over 145,000! Our readers work at top companies like Apple, Meta, OpenAI, Google, Microsoft, and many more.
If you want to share your company or product with fellow AI enthusiasts before we’re fully booked, reserve an ad slot here.